A PHASE 1 STUDY TO INVESTIGATE THE SAFETY, TOLERANCE, FOOD EFFECT, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE AND MULTIPLE DOSES OF EXTENDED RELEASE FORMULATIONS OF CENTANAFADINE (CTN) IN YOUNG HEALTHY SUBJECTS: